Boundless Bio, Inc. Common Stock
XNAS:BOLD
1.17
$1.18 - 148.00
$1.06 - 424.00
$1.1
$1.18
$1.15
$1.11
3.54
1
89740
228454.8
15912609.4
Chart
TendieTensor AI Analysis
Company
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
Fundamentals
64
-0.420000
0.237741
-0.62
100
BBG00Q4W34T4
BBG00Q4W34V1
22.39M
22.39M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own BOLD. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.